Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mike Reardon joins the board of Vidant Pharma

This article was originally published in Scrip

Executive Summary

Mike Reardon, chief executive of Xiota, has joined Vidant Pharma as a non-executive director. Vidant is about to launch its first product, Eradicil, a medicated laundry pre-wash that kills fungi and bacteria, onto the UK OTC pharmaceuticals market. The product, originally developed by Marion Merrell Dow (now part of Sanofi-Aventis), is already available in Europe as an adjunct to other treatments for dermatological infections.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC000830

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel